Bard Associates’s Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 SRTSW Stock Holding History

Bard Associates’s Portfolio SRTSW Stock Details SRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-67,900	Closed	-$34K	–	170
2019 Q1	$34K	Sell	67,900 -800	-1%	-$728	0.02%	163
2018 Q4	$67K	Sell	68,700 -1,500	-2%	-$1.98K	0.04%	161
2018 Q3	$153K	Buy	+70,200	New	+$107K	0.07%	149
2018 Q2	–	Hold	0	–	–	–	165
2018 Q1	–	Hold	0	–	–	–	169
2017 Q4	–	Hold	0	–	–	–	165
2017 Q3	–	Hold	0	–	–	–	171
2017 Q2	–	Hold	0	–	–	–	187
2017 Q1	–	Hold	0	–	–	–	171
2016 Q4	–	Hold	0	–	–	–	170
2016 Q3	–	Hold	0	–	–	–	158

Other funds holding SRTSW

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bard Associates's SRTSW Position: Q2 2019 in Review

Bard Associates sold out of Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 (SRTSW) in Q2 2019, closing a stake of 67,900 shares — an estimated $34K sold.

Bard Associates first reported a position in SRTSW in Q3 2018 and held it in 3 quarters. The position peaked at $153K in Q3 2018. 3 funds tracked by Wall St. Rank hold SRTSW as of Q2 2019.

Bard Associates reported no remaining Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 position as of Q2 2019 after selling out during the quarter.
Bard Associates sold 67,900 Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 shares in Q2 2019, an estimated $34K.
Bard Associates first reported a position in Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 in Q3 2018 and held it in 3 quarters.
Bard Associates's Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 position peaked at $153K in Q3 2018.
3 funds tracked by Wall St. Rank held Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 as of Q2 2019.

Based on Bard Associates's 13F filing for Q2 2019, filed 13 Aug 2019.